Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
Navarro-Jarabo JM, Fernández N, Sousa FL, Cabrera E, Castro M, Ramírez LM, Rivera R, Ubiña E, Vera F, Méndez I, Rivas-Ruiz F, Moreno JL, Perea-Milla E.
Navarro-Jarabo JM, et al.
BMC Gastroenterol. 2007 Jul 25;7:31. doi: 10.1186/1471-230X-7-31.
BMC Gastroenterol. 2007.
PMID: 17651479
Free PMC article.
Clinical Trial.